1- (alkylaminoalkyl-pyrolidin-/piperidinyl) - 2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists

Details for Australian Patent Application No. 2004253869 (hide)

Owner Theravance, Inc.

Inventors Li, Li; Mammen, Mathai; Ji, Yu-Hua; Zhang, Weijiang; Hughes, Adam

Agent Davies Collison Cave

Pub. Number AU-B-2004253869

PCT Pub. Number WO2005/003090

Priority 60/478,456 13.06.03 US

Filing date 10 June 2004

Wipo publication date 13 January 2005

Acceptance publication date 18 February 2010

International Classifications

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

C07D 207/08 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/34 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2005/003090 Priority application(s): WO2005/003090

18 February 2010 Application Accepted

  Published as AU-B-2004253869

17 June 2010 Standard Patent Sealed

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004253870-Compositions and methods for increasing bone mineralization

2004253868-Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereof